CONCERT PHARMACEUTICALS, INC. Annual Return On Equity in % from 2014 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2021.
  • Concert Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2022 was -112 %, a 97.8% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Return On Equity for 2021 was -71.5 %, a 33.2% decline from 2020.
  • Concert Pharmaceuticals, Inc. annual Return On Equity for 2020 was -53.6 %, a 13.5% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Return On Equity for 2019 was -62 %, a 111% decline from 2018.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -71.5 -17.8 -33.2% Jan 1, 2021 Dec 31, 2021
2020 -53.6 +8.38 +13.5% Jan 1, 2020 Dec 31, 2020
2019 -62 -32.7 -111% Jan 1, 2019 Dec 31, 2019
2018 -29.3 -101 -141% Jan 1, 2018 Dec 31, 2018
2017 72 +122 Jan 1, 2017 Dec 31, 2017
2016 -50 -69.7 -352% Jan 1, 2016 Dec 31, 2016
2015 19.8 +67.7 Jan 1, 2015 Dec 31, 2015
2014 -47.9 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.